AR103082A1 - Purificación de polisacárido capsular de estreptococos - Google Patents

Purificación de polisacárido capsular de estreptococos

Info

Publication number
AR103082A1
AR103082A1 ARP150104156A ARP150104156A AR103082A1 AR 103082 A1 AR103082 A1 AR 103082A1 AR P150104156 A ARP150104156 A AR P150104156A AR P150104156 A ARP150104156 A AR P150104156A AR 103082 A1 AR103082 A1 AR 103082A1
Authority
AR
Argentina
Prior art keywords
purification
capsular
polisacárid
streptococ
capsular polysaccharide
Prior art date
Application number
ARP150104156A
Other languages
English (en)
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of AR103082A1 publication Critical patent/AR103082A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Abstract

Un procedimiento de purificación para el polisacárido capsular de GBS de tipo II en la que el polisacárido capsular se filtra utilizando una membrana con un punto de corte de menos de 30 kDa. Este procedimiento proporciona un rendimiento más alto que los protocolos anteriores.
ARP150104156A 2014-12-19 2015-12-17 Purificación de polisacárido capsular de estreptococos AR103082A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14199441.8A EP3034516A1 (en) 2014-12-19 2014-12-19 Purification of streptococcal capsular polysaccharide

Publications (1)

Publication Number Publication Date
AR103082A1 true AR103082A1 (es) 2017-04-12

Family

ID=52231940

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150104156A AR103082A1 (es) 2014-12-19 2015-12-17 Purificación de polisacárido capsular de estreptococos

Country Status (6)

Country Link
US (1) US10172928B2 (es)
EP (3) EP3034516A1 (es)
AR (1) AR103082A1 (es)
BE (1) BE1023297B1 (es)
ES (1) ES2942133T3 (es)
WO (1) WO2016097147A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234770A (zh) * 2021-06-15 2021-08-10 广州知易生物科技有限公司 脆弱拟杆菌荚膜多糖a的制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
BE889979A (fr) 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4882317A (en) 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IT1187753B (it) 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
NL8802046A (nl) 1988-08-18 1990-03-16 Gen Electric Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
DE3841091A1 (de) 1988-12-07 1990-06-13 Behringwerke Ag Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
EP0378881B1 (en) 1989-01-17 1993-06-09 ENIRICERCHE S.p.A. Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
EP0482068A1 (en) 1989-07-14 1992-04-29 American Cyanamid Company Cytokine and hormone carriers for conjugate vaccines
IT1237764B (it) 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
DE69113564T2 (de) 1990-08-13 1996-05-30 American Cyanamid Co Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
IT1262896B (it) 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
ATE254475T1 (de) 1993-09-22 2003-12-15 Jackson H M Found Military Med Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
DE4432628B4 (de) * 1994-09-14 2008-01-10 Sartorius Biotech Gmbh Dead-End-Filtrationseinheit zur Abtrennung von Stoffen mit Membranadsorbern
CA2221511C (en) 1995-06-07 2013-01-08 Smithkline Beecham Biologicals S.A. Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
US6891037B1 (en) 1997-01-24 2005-05-10 Schweiz. Serum- & Impfinstitut Bern Method for the isolation of polysaccharides
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
EP2226336B1 (en) * 1997-12-23 2016-10-19 Pfizer Ireland Pharmaceuticals Bacterial capsular polysaccharide for use as vaccines or for linking to proteins in conjugate vaccines
US7018637B2 (en) 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
AU771330B2 (en) 1998-08-19 2004-03-18 Baxter Healthcare Sa Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
PL203917B1 (pl) 1999-03-19 2009-11-30 Glaxosmithkline Biolog Sa Kompozycja immunogenna, sposób jej wytwarzania oraz zastosowanie
AU781027B2 (en) 1999-04-09 2005-04-28 Department Of Health & Human Services Recombinant toxin a protein carrier for polysaccharide conjugate vaccines
GB0007432D0 (en) 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
AU2002309706A1 (en) 2001-05-11 2002-11-25 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
US20040096461A1 (en) 2002-07-30 2004-05-20 Baxter Healthcare Corporation Chimeric multivalent polysaccharide conjugate vaccines
US20070053924A1 (en) 2002-08-26 2007-03-08 Herve Tettelin Conserved and specific streptococcal genomes
GB0502095D0 (en) 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
GB0502096D0 (en) 2005-02-01 2005-03-09 Chiron Srl Purification of streptococcal capsular polysaccharide
JP5286089B2 (ja) * 2006-01-13 2013-09-11 バクスター・インターナショナル・インコーポレイテッド ポリサッカライドを精製する方法
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
JP2011515170A (ja) * 2008-03-28 2011-05-19 リサーチ ファンデーション フォー メディカル デバイシズ 溶媒／界面活性剤処理による生体液のウイルス不活化方法
EP2356135B1 (en) 2008-11-05 2017-10-25 Wyeth LLC Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
EP3140414B1 (en) 2014-05-07 2022-10-26 GlaxoSmithKline Biologicals S.A. Purification of secreted polysaccharides from s. agalactiae

Also Published As

Publication number Publication date
US20170348408A1 (en) 2017-12-07
ES2942133T3 (es) 2023-05-30
BE1023297A1 (fr) 2017-01-26
BE1023297B1 (fr) 2017-01-26
US10172928B2 (en) 2019-01-08
EP3034516A1 (en) 2016-06-22
EP4201965A1 (en) 2023-06-28
WO2016097147A1 (en) 2016-06-23
EP3233927B1 (en) 2023-03-08
EP3233927A1 (en) 2017-10-25

Similar Documents

Publication Publication Date Title
UY36315A (es) COMPUESTOS NOVEDOSOS ANTAGONISTAS DE INTEGRINA avß6.
DK3175122T3 (da) Trykvekslingssystem med motorsystem.
BR112016024816A2 (pt) sistema de filtragem de bolsa de ostomia
FI20165011A (fi) Menetelmä vähätuhkaisen aktiivihiilen valmistamiseksi
CL2014003042S1 (es) Carcasa para autoinyector.
BR112018002461A2 (pt) compostos para dispositivos opticamente ativos
CL2016001756A1 (es) Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular.
CL2016001349A1 (es) Uso de derivados de bencimidazol-prolina
EP3528931A4 (en) OSMOTIC MEMBRANE
SG11202002634WA (en) Dialysate free artificial kidney device
EP3441133A4 (en) SEMI-PERMEABLE MEMBRANE
DK3504432T3 (da) Højtryks brændstofspumpe
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
BR112018003903A2 (pt) sistema, método para filtrar luz polarizada e kit para usar com um sistema que tem lente birrefringente
EP3225299A4 (en) Multilayer semipermeable membrane
AR103082A1 (es) Purificación de polisacárido capsular de estreptococos
EP3864291C0 (de) Membranpumpe
EP3743617B8 (en) Fuel pump
EP3513074A4 (en) AUTOMATIC SELF-DRIVING PUMPS
CL2016003351A1 (es) Lipido que comprende ácido docosapentanoico
EP3210571A4 (en) Intraocular lens injector
PE20161133A1 (es) Filtros para equipos de infusion
ES1135382Y (es) Arqueta de filtracion para piscinas con preinstalacion para acople de suplementos
EP3145728A4 (en) Slant lens interlacing with linearly arranged lenses
ES2760174R1 (es) Tornillo tipo presion

Legal Events

Date Code Title Description
FB Suspension of granting procedure